CRISPR Therapeutics SEC Filings http://ir.crisprtx.com/ CRISPR Therapeutics SEC Filings en 4: Statement of changes in beneficial ownership of securities http://ir.crisprtx.com/sec-filings/sec-filing/4/0000899243-19-016947 CRISPR Therapeutics AG Thu, 13 Jun 2019 20:52:38 -0400 CRISPR Therapeutics SEC Filings 8916 3: Initial filing by director officer or owner of more than ten percent. http://ir.crisprtx.com/sec-filings/sec-filing/3/0000899243-19-016945 CRISPR Therapeutics AG Thu, 13 Jun 2019 20:44:38 -0400 CRISPR Therapeutics SEC Filings 8911 4: Statement of changes in beneficial ownership of securities http://ir.crisprtx.com/sec-filings/sec-filing/4/0001209191-19-036843 CRISPR Therapeutics AG Thu, 13 Jun 2019 17:12:31 -0400 CRISPR Therapeutics SEC Filings 8906 4: Statement of changes in beneficial ownership of securities http://ir.crisprtx.com/sec-filings/sec-filing/4/0000899243-19-016847 CRISPR Therapeutics AG Thu, 13 Jun 2019 17:08:35 -0400 CRISPR Therapeutics SEC Filings 8896 4: Statement of changes in beneficial ownership of securities http://ir.crisprtx.com/sec-filings/sec-filing/4/0000899243-19-016846 CRISPR Therapeutics AG Thu, 13 Jun 2019 17:08:35 -0400 CRISPR Therapeutics SEC Filings 8901 4: Statement of changes in beneficial ownership of securities http://ir.crisprtx.com/sec-filings/sec-filing/4/0000899243-19-016843 CRISPR Therapeutics AG Thu, 13 Jun 2019 17:08:32 -0400 CRISPR Therapeutics SEC Filings 8891 4: Statement of changes in beneficial ownership of securities http://ir.crisprtx.com/sec-filings/sec-filing/4/0000899243-19-016845 CRISPR Therapeutics AG Thu, 13 Jun 2019 17:08:31 -0400 CRISPR Therapeutics SEC Filings 8886 3: Initial filing by director officer or owner of more than ten percent. http://ir.crisprtx.com/sec-filings/sec-filing/3/0000899243-19-016831 CRISPR Therapeutics AG Thu, 13 Jun 2019 16:58:31 -0400 CRISPR Therapeutics SEC Filings 8881 8-K: Report of unscheduled material events or corporate event http://ir.crisprtx.com/sec-filings/sec-filing/8-k/0001193125-19-172545 CRISPR Therapeutics AG Thu, 13 Jun 2019 16:46:30 -0400 CRISPR Therapeutics SEC Filings 8876 4: Statement of changes in beneficial ownership of securities http://ir.crisprtx.com/sec-filings/sec-filing/4/0000899243-19-016636 CRISPR Therapeutics AG Wed, 12 Jun 2019 16:20:28 -0400 CRISPR Therapeutics SEC Filings 8861